Treatment Action Group

TAG statement on BCG vaccine and COVID-19

More research required to determine if century-old TB vaccine protects against SARS-CoV-2 infection or severe COVID-19 disease.

Read More →

Webinar recording: Fair pricing for Cepheid Xpert tests (COVID-19, HIV, TB, HCV)

On 3 April 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, and the Global Coalition of TB Activists (GCTA) held a webinar on the price of Xpert tests for COVID-19, HIV, TB, HCV and other diseases. The webinar provided the latest information about the “Time for $5” campaign and the evidence base for why GeneXpert tests should be priced at US$5.

Read More →

TAG statement on the high price of Cepheid’s Xpert test for COVID-19

Cepheid is profiteering during a pandemic, with dangerous consequences for countries with vulnerable populations and health systems.

Read More →

CROI 2020 TB round up

Treatment Action Group (TAG) released an overview of TB data reported at the 2020 Conference on Retroviruses and Opportunistic Infections (CROI) virtually held on 8-11 March 2020. A summary of major findings, TAG’s take on them, and high-level summaries of select findings are available here.

Read More →

An Activist's Guide to the TB LAM Test

Treatment Action Group releases an updated version of its Activist’s Guide to the LAM Test with a complementary resource that tracks the status of LAM uptake in the 30 high TB/HIV burden countries.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs - webinar materials now available online

Treatment Action Group, Médecins Sans Frontières and Health GAP conducted a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

Webinar: What’s New—and Next—for TB Vaccines

Treatment Action Group (TAG) and AVAC will host a webinar on 6 February 2020 featuring an update on recent vaccine results and possible next steps with M72/AS01E, one of several new TB vaccine candidates.

Read More →

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia

Activists urge Sanofi to do the same in other countries.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs

Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

Page 2 of 16 · Total posts: 10

←First 1 2 3 Last→